MTHFR and Rare hereditary thrombophilia: Of particular note is the inclusion of certain polymorphisms, such as MTHFR C677T and PAI-1 4G/4G, which are no longer regarded as clinically relevant markers of inherited thrombophilia under current international guidelines.